Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hypermarcas ADR (HYPMY)

Hypermarcas ADR (HYPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,970,745
  • Shares Outstanding, K 633,421
  • Annual Sales, $ 1,380 M
  • Annual Income, $ 248,620 K
  • EBIT $ -38 M
  • EBITDA $ 390 M
  • 60-Month Beta 0.73
  • Price/Sales 2.23
  • Price/Cash Flow 10.28
  • Price/Book 1.54
  • Price/Earnings ttm 21.13
  • Earnings Per Share ttm 0.23
  • Most Recent Earnings $0.13 on 11/12/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.14 (2.92%)
  • Most Recent Dividend 0.036 on 10/06/25
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/16
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.07
  • Growth Rate Est. (year over year) +1,427,042.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.5000 +4.22%
on 11/06/25
5.1800 -9.46%
on 12/02/25
+0.0550 (+1.19%)
since 11/05/25
3-Month
3.7100 +26.42%
on 10/14/25
5.1800 -9.46%
on 12/02/25
+0.4750 (+11.27%)
since 09/05/25
52-Week
2.6400 +77.65%
on 12/18/24
5.1800 -9.46%
on 12/02/25
+1.4150 (+43.21%)
since 12/05/24

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.

See More

Key Turning Points

3rd Resistance Point 5.1317
2nd Resistance Point 5.0433
1st Resistance Point 4.8667
Last Price 4.6900
1st Support Level 4.6017
2nd Support Level 4.5133
3rd Support Level 4.3367

See More

52-Week High 5.1800
Last Price 4.6900
Fibonacci 61.8% 4.2097
Fibonacci 50% 3.9100
Fibonacci 38.2% 3.6103
52-Week Low 2.6400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar